{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:12:47Z","timestamp":1793445167581,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jpeds.2021.05.016","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T22:16:17Z","timestamp":1620857777000},"page":"204-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Invasive Fungal Infections in Immunocompromised Children: Novel Insight Following a National Study"],"prefix":"10.1016","volume":"236","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2908-5768","authenticated-orcid":false,"given":"Laura","family":"Olivier-Gougenheim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1614-7755","authenticated-orcid":false,"given":"Nicolas","family":"Rama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Saultier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Leverger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wadih","family":"AbouChahla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Paillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Gandemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Theron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Freycon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Pluchart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Blouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Pellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Thouvenin-Doulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Desplantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Ducassou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Oudot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremie","family":"Rouger-Gaudichon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3403-3842","authenticated-orcid":false,"given":"Nathalie","family":"Cheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryline","family":"Poiree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Plat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Contet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Rialland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Gouache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0663-3429","authenticated-orcid":false,"given":"Benoit","family":"Brethon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Domenech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2021.05.016_bib1","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/S1470-2045(14)70017-8","article-title":"Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation","volume":"15","author":"Groll","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jpeds.2021.05.016_bib2","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1080\/14787210.2016.1242413","article-title":"Diagnosis of invasive fungal diseases in pediatric patients","volume":"14","author":"Pana","year":"2016","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"Suppl 1","key":"10.1016\/j.jpeds.2021.05.016_bib3","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/jpids\/pix046","article-title":"Epidemiology of invasive fungal disease in children","volume":"6","author":"Pana","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.jpeds.2021.05.016_bib4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jinf.2010.06.018","article-title":"Trends in the postmortem epidemiology of invasive fungal infections at a university hospital","volume":"61","author":"Lehrnbecher","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.jpeds.2021.05.016_bib5","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/j.1469-0691.2010.03336.x","article-title":"Diagnosis of invasive fungal infections in immunocompromised children","volume":"16","author":"Dornbusch","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jpeds.2021.05.016_bib6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/ejh.12910","article-title":"Retrospective study on the incidence and outcome of proven and probable invasive fungal infections in high-risk pediatric onco-hematological patients","volume":"99","author":"Cesaro","year":"2017","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jpeds.2021.05.016_bib7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1099\/0022-1317-51-7-601","article-title":"A prospective study on fungal infection in children with cancer","volume":"51","author":"El-Mahallawy","year":"2002","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jpeds.2021.05.016_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/01.mph.0000155861.38641.ca","article-title":"Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution","volume":"27","author":"Rosen","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jpeds.2021.05.016_bib9","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/14787210.2019.1626718","article-title":"The clinical management of invasive mold infection in children with cancer or undergoing hematopoietic stem cell transplantation","volume":"17","author":"Lehrnbecher","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jpeds.2021.05.016_bib10","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/MPH.0b013e3181864a80","article-title":"The clinical feature of invasive fungal infection in pediatric patients with hematologic and malignant diseases: a 10-year analysis at a single institution at Japan","volume":"30","author":"Kobayashi","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jpeds.2021.05.016_bib11","doi-asserted-by":"crossref","first-page":"e27915","DOI":"10.1002\/pbc.27915","article-title":"Invasive fungal infections in children with acute lymphoblastic leukaemia: results from four Australian centres, 2003-2013","volume":"66","author":"Wang","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2021.05.016_bib12","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/pbc.23005","article-title":"Invasive fungal\u00a0infections in pediatric oncology","volume":"56","author":"Mor","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2021.05.016_bib13","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/01.inf.0000220256.69385.2e","article-title":"Fungal infections in children with cancer: a prospective, multicenter surveillance study","volume":"25","author":"Castagnola","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2021.05.016_bib14","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/myc.12990","article-title":"Epidemiology and outcome of invasive fungal disease in children after hematopoietic cell transplantation or treated for malignancy: impact of national programme of antifungal prophylaxis","volume":"62","author":"Czy\u017cewski","year":"2019","journal-title":"Mycoses"},{"key":"10.1016\/j.jpeds.2021.05.016_bib15","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/pbc.21868","article-title":"Invasive fungal infections in pediatric leukemia patients receiving fluconazole prophylaxis","volume":"52","author":"Kaya","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2021.05.016_bib16","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/INF.0000000000002010","article-title":"Risk factors for invasive fungal infection in children and adolescents with hematologic and malignant diseases: a 10-year analysis in a single institute in Japan","volume":"37","author":"Kobayashi","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2021.05.016_bib17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00006454-200203000-00013","article-title":"Infections diagnosed in the first year after pediatric stem cell transplantation","volume":"21","author":"Benjamin","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2021.05.016_bib18","doi-asserted-by":"crossref","first-page":"e382","DOI":"10.1038\/bcj.2015.110","article-title":"Infectious complications in children with acute myeloid leukemia: decreased mortality in multicenter trial AML-BFM 2004","volume":"6","author":"Bochennek","year":"2016","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jpeds.2021.05.016_bib19","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/MPH.0000000000000629","article-title":"Invasive fungal disease in pediatric patients undergoing allogeneic hematopoietic stem cell transplant","volume":"38","author":"Aftandilian","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jpeds.2021.05.016_bib20","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.bmt.1705113","article-title":"Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation","volume":"36","author":"Dvorak","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jpeds.2021.05.016_bib21","doi-asserted-by":"crossref","first-page":"e13070","DOI":"10.1111\/petr.13070","article-title":"Early bacterial and fungal infection in children receiving allogeneic stem cell transplantation for acute lymphoblastic leukemia in Argentina","volume":"22","author":"Gomez","year":"2018","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jpeds.2021.05.016_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/bmt.2013.136","article-title":"Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients","volume":"49","author":"Hol","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jpeds.2021.05.016_bib23","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/sj.bmt.1702654","article-title":"Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years","volume":"26","author":"Hovi","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jpeds.2021.05.016_bib24","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1093\/jac\/dky244","article-title":"Efficacy of pre-emptive versus empirical antifungal therapy in children with cancer and high-risk febrile neutropenia: a randomized clinical trial","volume":"73","author":"Santolaya","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jpeds.2021.05.016_bib25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/ejh.12685","article-title":"Impact of a change in protected environment on the occurrence of severe bacterial and fungal infections in children undergoing\u00a0hematopoietic stem cell transplantation","volume":"97","author":"Libbrecht","year":"2016","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jpeds.2021.05.016_bib26","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/pbc.22750","article-title":"Incidence of bacteremias and invasive mycoses in children with acute non-lymphoblastic leukemia: results from a multi-center Italian study","volume":"55","author":"Castagnola","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2021.05.016_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/INF.0000000000000101","article-title":"Role of management strategies in reducing mortality from invasive fungal disease in children with cancer or receiving hemopoietic stem cell transplant: a single center 30-year experience","volume":"33","author":"Castagnola","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2021.05.016_bib28","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/s41409-018-0160-2","article-title":"Risk factors associated with development and mortality by invasive fungal diseases in pediatric allogeneic stem cell transplantation. A pediatric subgroup analysis of data from a prospective study of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)","volume":"53","author":"Castagnola","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jpeds.2021.05.016_bib29","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1097\/INF.0000000000000875","article-title":"Invasive fungal infections in pediatric acute myelogenous leukemia","volume":"34","author":"Ducassou","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2021.05.016_bib30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2141.2009.08072.x","article-title":"Epidemiology of paediatric invasive fungal infections and a case-control study of risk factors in acute leukaemia or post stem cell transplant","volume":"149","author":"Hale","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jpeds.2021.05.016_bib31","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/s12098-018-2722-0","article-title":"Prevalence and predictors of invasive fungal infections in children with persistent febrile neutropenia treated for acute leukemia \u2013 a prospective study","volume":"85","author":"Kumar","year":"2018","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.jpeds.2021.05.016_bib32","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ejca.2011.01.021","article-title":"Time for paediatric febrile neutropenia guidelines \u2013 children are not little adults","volume":"47","author":"Sung","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jpeds.2021.05.016_bib33","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/INF.0b013e3181b076b1","article-title":"Invasive fungal infections in children","volume":"28","author":"Dornbusch","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2021.05.016_bib34","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/bcp.12025","article-title":"Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective","volume":"75","author":"Lestner","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jpeds.2021.05.016_bib35","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1038\/sj.leu.2403932","article-title":"Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report","volume":"19","author":"Entz-Werle","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.jpeds.2021.05.016_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/MPH.0000000000001034","article-title":"Acute myeloid leukemia with central nervous system involvement in children: experience from the French Protocol Analysis ELAM02","volume":"40","author":"Felix","year":"2018","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jpeds.2021.05.016_bib37","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S1470-2045(12)70377-7","article-title":"Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study","volume":"13","author":"Biondi","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jpeds.2021.05.016_bib38","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.ejca.2008.08.007","article-title":"First isolated extramedullary relapse in children with B-cell precursor acute lymphoblastic leukaemia: results of the Cooprall-97 study","volume":"44","author":"Domenech","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jpeds.2021.05.016_bib39","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jpeds.2021.05.016_bib40","author":"Carstensen"},{"key":"10.1016\/j.jpeds.2021.05.016_bib41","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3389\/fmicb.2019.00681","article-title":"Incidence and outcome of invasive fungal diseases in children with hematological malignancies and\/or allogeneic hematopoietic stem cell transplantation: results of a prospective multicenter study","volume":"10","author":"Lehrnbecher","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jpeds.2021.05.016_bib42","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/pai.13239","article-title":"Infectious complications after hematopoietic stem cell transplantation for primary immunodeficiency in children: a multicenter nationwide study","volume":"31","author":"Zaj\u0105c-Spycha\u0142a","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jpeds.2021.05.016_bib43","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/sj.leu.2403188","article-title":"Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93","volume":"18","author":"Lehrnbecher","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.jpeds.2021.05.016_bib44","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1182\/blood-2007-05-091942","article-title":"Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia","volume":"110","author":"Sung","year":"2007","journal-title":"Blood"},{"issue":"suppl 5","key":"10.1016\/j.jpeds.2021.05.016_bib45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1469-0691.2009.02988.x","article-title":"Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?","volume":"15","author":"Pongas","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jpeds.2021.05.016_bib46","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1080\/10428194.2016.1204652","article-title":"Epidemiology of invasive fungal infections during induction therapy in adults with acute lymphoblastic leukemia: a GRAALL-2005 study","volume":"58","author":"Mariette","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jpeds.2021.05.016_bib47","doi-asserted-by":"crossref","first-page":"e0197851","DOI":"10.1371\/journal.pone.0197851","article-title":"Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: a retrospective cohort study","volume":"13","author":"Lien","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jpeds.2021.05.016_bib48","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/myc.12646","article-title":"Invasive fungal infection following chemotherapy for acute myeloid leukaemia\u2014experience from a developing country","volume":"60","author":"Korula","year":"2017","journal-title":"Mycoses"},{"key":"10.1016\/j.jpeds.2021.05.016_bib49","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1200\/JCO.2016.71.7017","article-title":"Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update","volume":"35","author":"Lehrnbecher","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpeds.2021.05.016_bib50","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/cid\/ciw592","article-title":"Galactomannan, \u03b2-D-glucan, and polymerase chain reaction-based assays for the diagnosis of invasive fungal disease in pediatric cancer and hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"63","author":"Lehrnbecher","year":"2016","journal-title":"Clin Infect Dis"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002234762100439X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002234762100439X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:10:36Z","timestamp":1758359436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002234762100439X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":50,"alternative-id":["S002234762100439X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2021.05.016","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invasive Fungal Infections in Immunocompromised Children: Novel Insight Following a National Study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2021.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}